Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-81.1%
5Y CAGR-88.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-81.1%/yr
Annual compound
5Y CAGR
-88.4%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.73 | -83.1% |
| 2023 | 16.14 | +67.6% |
| 2022 | 9.63 | -97.6% |
| 2021 | 402.58 | -99.2% |
| 2020 | 50763.52 | -60.8% |
| 2019 | 129529.84 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |